Barriers to Increasing Prescription Drug Monitoring Program Use A Multidisciplinary Perspective

被引:1
作者
Marie, Barbara J. St J. [1 ]
Witry, Matthew J. [2 ]
Reist, Jeffrey C. [2 ]
机构
[1] Univ Iowa, Coll Nursing, 50 Newton Rd,Ste 440, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA
关键词
Interface; Multidisciplinary; Prescribing; Prescription drug monitoring program; Qualitative research; EMERGENCY-DEPARTMENT; IMPACT; IMPLEMENTATION;
D O I
10.1097/CIN.0000000000000997
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Prescription drug monitoring programs are implemented through individual state policies and are one solution to curb the opioid crisis. The objectives of this study are to: (1) describe the multidisciplinary experiences using this program in practice; (2) identify limitations of the program and the desired features for improvement; and (3) characterize expectations for improved access when prescription drug monitoring programs are embedded in the electronic health record. A qualitative descriptive study design used semistructured interviews of 15 multidisciplinary healthcare providers. Textual data were analyzed using content analysis. Results showed the prescription drug monitoring program was helpful to decision-making processes related to opioid prescribing and referral to treatment; there were barriers limiting healthcare providers' use of the prescription drug monitoring program; preferences were delineated for integrating prescription drug monitoring program into electronic health record; and recommendations were provided to improve the program and increase use. In conclusion, the prescription drug monitoring program was viewed as useful in making strides to reduce the impact of inappropriate opioid prescribing in our country. By engaging a multidisciplinary group of healthcare providers, solutions were offered to improve the interface and function of the prescription drug monitoring program to assist in increasing use.
引用
收藏
页码:556 / 562
页数:7
相关论文
共 30 条
  • [1] The Impact of a PDMP-EHR Data Integration Combined With Clinical Decision Support on Opioid and Benzodiazepine Prescribing Across Clinicians in a Metropolitan Area
    Calcaterra, Susan L.
    Butler, Maria
    Olson, Katie
    Blum, Joshua
    [J]. JOURNAL OF ADDICTION MEDICINE, 2022, 16 (03) : 324 - 332
  • [2] Prescription Drug Monitoring Programs and Opioid Overdoses Exploring Sources of Heterogeneity
    Castillo-Carniglia, Alvaro
    Ponicki, William R.
    Gaidus, Andrew
    Gruenewald, Paul J.
    Marshall, Brandon D. L.
    Fink, David S.
    Martins, Silvia S.
    Rivera-Aguirre, Ariadne
    Wintemute, Garen J.
    Cerda, Magdalena
    [J]. EPIDEMIOLOGY, 2019, 30 (02) : 212 - 220
  • [3] Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers
    Deyo, Richard A.
    Hallvik, Sara E.
    Hildebran, Christi
    Marino, Miguel
    Springer, Rachel
    Irvine, Jessica M.
    O'Kane, Nicole
    Van Otterloo, Joshua
    Wright, Dagan A.
    Leichtling, Gillian
    Millet, Lisa M.
    Carson, Jody
    Wakeland, Wayne
    McCarty, Dennis
    [J]. JOURNAL OF PAIN, 2018, 19 (02) : 166 - 177
  • [4] The qualitative content analysis process
    Elo, Satu
    Kyngaes, Helvi
    [J]. JOURNAL OF ADVANCED NURSING, 2008, 62 (01) : 107 - 115
  • [5] Utilization of prescription drug monitoring programs for prescribing and dispensing decisions: Results from a multi-site qualitative study
    Freeman, Patricia R.
    Curran, Geoffrey M.
    Drummond, Karen L.
    Martin, Bradley C.
    Teeter, Benjamin S.
    Bradley, Katharine
    Schoenberg, Nancy
    Edlund, Mark J.
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2019, 15 (06) : 754 - 760
  • [6] Medical error and human factors engineering: Where are we now?
    Gawron, VJ
    Drury, CG
    Fairbanks, RJ
    Berger, RC
    [J]. AMERICAN JOURNAL OF MEDICAL QUALITY, 2006, 21 (01) : 57 - 67
  • [7] Human factors engineering and patient safety
    Gosbee, J
    [J]. QUALITY & SAFETY IN HEALTH CARE, 2002, 11 (04): : 352 - 354
  • [8] What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose
    Haegerich, Tamara M.
    Paulozzi, Leonard J.
    Manns, Brian J.
    Jones, Christopher M.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2014, 145 : 34 - 47
  • [9] RIGOR IN FEMINIST RESEARCH
    HALL, JM
    STEVENS, PE
    [J]. ADVANCES IN NURSING SCIENCE, 1991, 13 (03) : 16 - 29
  • [10] Evaluation of Prescription Drug Monitoring Program Integration With Hospital Electronic Health Records by US County-Level Opioid Prescribing Rates
    Holmgren, A. Jay
    Apathy, Nate C.
    [J]. JAMA NETWORK OPEN, 2020, 3 (06) : E209085